» Articles » PMID: 24295611

Body Mass Index and Early Kidney Function Decline in Young Adults: a Longitudinal Analysis of the CARDIA (Coronary Artery Risk Development in Young Adults) Study

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2013 Dec 4
PMID 24295611
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Identifying potentially modifiable risk factors is critically important for reducing the burden of chronic kidney disease. We sought to examine the association of body mass index (BMI) with kidney function decline in a cohort of young adults with preserved glomerular filtration at baseline.

Study Design: Longitudinal cohort.

Setting & Participants: 2,839 black and white young adults with cystatin C-based estimated glomerular filtration rate (eGFRcys)>90mL/min/1.73m(2) taking part in the year-10 examination (in 1995-1996) of the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Predictor: BMI, categorized as 18.5-24.9 (reference), 25.0-29.9, 30.0-39.9, and ≥40.0kg/m(2).

Outcomes: Trajectory of kidney function decline, rapid decline (>3% per year), and incident eGFRcys <60mL/min/1.73m(2) over 10 years of follow-up.

Measurements: GFRcys estimated from the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation for calibrated cystatin C at CARDIA years 10, 15, and 20.

Results: At year 10, participants had a mean age of 35.1 years, median eGFRcys of 114mL/min/1.73m(2), and 24.5% had BMI≥30.0kg/m(2). After age 30 years, average eGFRcys was progressively lower with each increment in BMI after adjustment for baseline age, race, sex, hyperlipidemia, smoking status, and physical activity. Higher BMI category was associated with successively higher odds of rapid decline (for 25.0-29.9, 30.0-39.9, and ≥40.0kg/m(2), adjusted ORs were 1.50 [95% CI, 1.21-1.87], 2.01 [95% CI, 1.57-2.87], and 2.57 [95% CI, 1.67-3.94], respectively). 18 participants (0.6%) had incident eGFRcys<60mL/min/1.73m(2). In unadjusted analysis, higher BMI category was associated with incident eGFRcys<60mL/min/1.73m(2) (for 25.0-29.9, 30.0-39.9, and ≥40.0kg/m(2), ORs were 5.17 [95% CI, 1.10-25.38], 7.44 [95% CI, 1.54-35.95], and 5.55 [95% CI, 0.50-61.81], respectively); adjusted associations were no longer significant.

Limitations: Inability to describe kidney function before differences by BMI category were already evident. Absence of data for measured GFR or GFR estimated from serum creatinine level.

Conclusions: Higher BMI categories are associated with greater declines in kidney function in a cohort of young adults with preserved GFR at baseline. Clinicians should vigilantly monitor overweight and obese patients for evidence of early kidney function decline.

Citing Articles

Long-term trajectory of estimated glomerular filtration rate in ambulatory patients with type 2 diabetes and heart failure: clinical insights and prognostic implications.

Julian M, Codina P, Lupon J, Zamora E, Perez-Montes de Oca A, Domingo M Cardiovasc Diabetol. 2025; 24(1):104.

PMID: 40045364 PMC: 11884049. DOI: 10.1186/s12933-025-02632-9.


Drug Development in Pediatric Chronic Kidney Disease: A Review of Promising Treatments, Old Challenges, and New Strategies.

Kula A Paediatr Drugs. 2025; .

PMID: 39928268 DOI: 10.1007/s40272-025-00684-8.


The association between the body roundness index and the risk of chronic kidney disease in US adults.

Zhang J, Yu X Front Med (Lausanne). 2025; 11:1495935.

PMID: 39744532 PMC: 11688310. DOI: 10.3389/fmed.2024.1495935.


Prevalence and progression of chronic kidney disease among adults undergoing creatinine testing in South African public healthcare facilities: a study leveraging data from South Africa's National Health Laboratory Service (NHLS).

Brennan A, Kileel E, Khoza S, Crowther N, Bor J, Fox M BMJ Public Health. 2024; 2(1).

PMID: 39698394 PMC: 11654635. DOI: 10.1136/bmjph-2023-000799.


Associations of physiologic subtypes based on HOMA2 indices of β-cell function and insulin sensitivity with the risk of kidney function decline, cardiovascular disease, and all-cause mortality from the 4C study.

Luo P, Li D, Guo Y, Meng X, Kan R, Pan L Cardiovasc Diabetol. 2024; 23(1):401.

PMID: 39511523 PMC: 11546320. DOI: 10.1186/s12933-024-02496-5.


References
1.
Fox C, Larson M, Leip E, Culleton B, Wilson P, Levy D . Predictors of new-onset kidney disease in a community-based population. JAMA. 2004; 291(7):844-50. DOI: 10.1001/jama.291.7.844. View

2.
Vupputuri S, Fox C, Coresh J, Woodward M, Muntner P . Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index. Am J Kidney Dis. 2009; 53(6):993-1001. PMC: 3028436. DOI: 10.1053/j.ajkd.2008.12.043. View

3.
Vivante A, Golan E, Tzur D, Leiba A, Tirosh A, Skorecki K . Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med. 2012; 172(21):1644-50. PMC: 4941233. DOI: 10.1001/2013.jamainternmed.85. View

4.
Silverwood R, Pierce M, Thomas C, Hardy R, Ferro C, Sattar N . Association between younger age when first overweight and increased risk for CKD. J Am Soc Nephrol. 2013; 24(5):813-21. PMC: 3636792. DOI: 10.1681/ASN.2012070675. View

5.
Gelber R, Kurth T, Kausz A, Manson J, Buring J, Levey A . Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005; 46(5):871-80. DOI: 10.1053/j.ajkd.2005.08.015. View